BRAIN TUMOR INVASION
BRAIN TUMOR INVASION
批准号:
2266240
负责人:
MICHAEL E. BERENS
金额:
$11.2万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-01 至 1997-06-30
关键词:
antineoplastics astrocytes athymic mouse brain cell brain neoplasms cell migration circulating neoplastic cell endopeptidases enzyme activity epidermal growth factor extracellular matrix proteins gel electrophoresis gene expression glioma immunocytochemistry immunofluorescence technique immunoprecipitation integrins lysophospholipids mixed tissue /cell culture neoplasm /cancer invasiveness neoplasm /cancer transplantation neoplastic cell northern blottings polymerase chain reaction protease inhibitor western blottings
中文摘要
该项目的长期目标是确定机制
英文摘要
The long term objectives of this project are to determine the mechanisms
of malignant glioma invasion in the brain and to devise a means to block
this behavior. We hypothesize that glioma cells are locally invasive
because of alterations in the expression of genes which regulate
interactions between cells and their extracellular environment.
Specifically, this project proposes: 1) to compare normal and tumorigenic
glial cells for their constitutive and stimulated production of matrix--
degrading proteinases. Cell-conditioned medium and membrane fractions
from control and epidermal growth factor-stimulated cells will be studied
for enzymatic activity using substrate gel electrophoresis (zymograms);
post-secretory regulation of proteolytic activity by activators or
inhibitors and proteinase receptors on the cells will be measured. 2) to
determine the mechanisms and extent to which specific-matrix proteins
influence glioma cell growth, migration and invasion. The expression of
specific matrix receptors (integrins) by glioma cells will be studied
using functional assays and quantified by northern and western blots.
Invasiveness will be measured in vitro by determining the quantitative
replacement of three dimensional aggregates of murine brain cells by
glioma cells during coculture, and in vivo using intracranial xenografts
in athymic mice. 3) to determine the mechanism by which treatment of
glioma cells with membrane active agents interferes with invasion of
brain in vitro and in vivo. The results from our studies should help to
develop a means to therapeutically block the local spread of glioma cells
which may convert glial neoplasms into more readily resectable tumors
and/or render them more amenable to focal treatment by radiation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
-
批准号:10488225
-
项目类别:
-
资助金额:$20.06万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
-
批准号:10696195
-
项目类别:
-
资助金额:$19.62万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Molecular Profiling and Bioinformatics
-
批准号:10306303
-
项目类别:
-
资助金额:$13.09万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Molecular Profiling and Bioinformatics
-
批准号:10488209
-
项目类别:
-
资助金额:$13.11万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Molecular Profiling and Bioinformatics
-
批准号:10696184
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Signature-guided treatment of GBM with neddylation inhibitor pevonedistat
-
批准号:10306306
-
项目类别:
-
资助金额:$23.47万
-
财政年份:2021
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10463734
-
项目类别:
-
资助金额:$54.89万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10023719
-
项目类别:
-
资助金额:$58.95万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10263186
-
项目类别:
-
资助金额:$25.11万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Core C: Experimental Models
-
批准号:10653109
-
项目类别:
-
资助金额:$54.82万
-
财政年份:2020
-
负责人:MICHAEL E. BERENS
-
依托单位:
Credentialing murine models for glioblastoma preclinical drug development
-
批准号:9986359
-
项目类别:
-
资助金额:$47.23万
-
财政年份:2016
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8323848
-
项目类别:
-
资助金额:$88.71万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8663201
-
项目类别:
-
资助金额:$78.85万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8464685
-
项目类别:
-
资助金额:$78.3万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:8850252
-
项目类别:
-
资助金额:$80.56万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
Systematic Development of Novel, Druggable Cancer Targets
-
批准号:9057986
-
项目类别:
-
资助金额:$79.42万
-
财政年份:2012
-
负责人:MICHAEL E. BERENS
-
依托单位:
The Southwest Comprehensive Center for Drug Discovery and Development
-
批准号:7942802
-
项目类别:
-
资助金额:$270.05万
-
财政年份:2009
-
负责人:MICHAEL E. BERENS
-
依托单位:
Arrested migration fosters apoptosis of glioma cells
-
批准号:6805713
-
项目类别:
-
资助金额:$21.97万
-
财政年份:2003
-
负责人:MICHAEL E. BERENS
-
依托单位:
Arrested migration fosters apoptosis of glioma cells
-
批准号:6582331
-
项目类别:
-
资助金额:$19.31万
-
财政年份:2003
-
负责人:MICHAEL E. BERENS
-
依托单位:
Genetic Pathways of Glioma Invasion
-
批准号:6530031
-
项目类别:
-
资助金额:$44.77万
-
财政年份:2001
-
负责人:MICHAEL E. BERENS
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: